In 2021, the market for Bio-Imaging worldwide was worth $33 billion US dollars. AMR Group projects that the market will reach US$ 48 billion by 2031, growing at a CAGR of 5 percent between 2022 and 2031.
Industry Overview
Bio-imaging is a technology used to visualize biological structures and processes, allowing researchers and healthcare professionals to study living organisms at a cellular and molecular level. It involves the use of various imaging techniques, such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound, and optical imaging, among others. The bio-imaging market includes a wide range of applications, including preclinical research, drug discovery, diagnostics, and personalized medicine. Bio-imaging is used in various fields, such as neuroscience, oncology, cardiology, and immunology, among others.
The bio-imaging market is driven by the increasing prevalence of chronic diseases, such as cancer and cardiovascular diseases, and the growing demand for non-invasive diagnostic procedures. The market is also driven by the development of advanced imaging technologies, such as molecular imaging and hybrid imaging, which can provide more accurate and detailed information about the biological processes. The bio-imaging market is highly competitive, with a large number of players operating in the market. The major players in the market are investing in research and development to develop advanced imaging technologies and applications, such as AI-powered imaging and multi-modal imaging, to stay ahead of the competition. The market for bio-imaging can be segmented based on various factors, including technology, application, end-user, and geography. The key technologies used in bio-imaging include MRI, CT, X-ray, ultrasound, and optical imaging, among others. The applications of bio-imaging include preclinical research, drug discovery, diagnostics, and personalized medicine. The end-users of bio-imaging include hospitals, research institutions, and pharmaceutical companies, among others. Geographically, the market can be segmented into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa.
Market Dynamics
The bio-imaging market is driven by various factors, including: Increasing prevalence of chronic diseases: The growing prevalence of chronic diseases, such as cancer, cardiovascular diseases, and neurological disorders, is driving the demand for bio-imaging technologies. These technologies are used for early diagnosis, treatment planning, and monitoring of these diseases.
Technological advancements: The development of advanced imaging technologies, such as molecular imaging and hybrid imaging, is driving the growth of the bio-imaging market. These technologies provide more accurate and detailed information about the biological processes and help in improving the diagnosis and treatment of diseases.
Growing demand for non-invasive diagnostic procedures: The increasing preference for non-invasive diagnostic procedures is driving the demand for bio-imaging technologies. These technologies provide a non-invasive way to visualize biological structures and processes and help in reducing the risk of complications associated with invasive procedures.
Increasing healthcare expenditure: The growing healthcare expenditure in both developed and developing countries is driving the demand for bio-imaging technologies. These technologies are used in various healthcare settings, such as hospitals, research institutions, and pharmaceutical companies, among others.
Rising demand for personalized medicine: The increasing demand for personalized medicine is driving the growth of the bio-imaging market. Bio-imaging technologies are used in personalized medicine to tailor the treatment to the individual patient based on their specific disease and biology. However, the high cost of bio-imaging technologies and the lack of skilled professionals to operate these technologies are some of the major challenges faced by the bio-imaging market. The market is also highly competitive, with a large number of players operating in the market, which makes it difficult for new players to enter the market.
COVID Impact
The COVID-19 pandemic has had a significant impact on the bio-imaging market. Here are some of the key impacts: Delayed and cancelled procedures: Due to the pandemic, many non-urgent medical procedures, including imaging procedures, were cancelled or delayed. This has resulted in a decline in the demand for bio-imaging technologies.
Supply chain disruptions: The COVID-19 pandemic has disrupted global supply chains, leading to shortages of critical components and equipment required for bio-imaging technologies. This has resulted in delays in the delivery of imaging equipment and increased prices.
Shift towards remote imaging: The pandemic has led to an increased demand for remote imaging technologies, such as tele-radiology and tele-ultrasound, to reduce the risk of exposure to the virus. This has led to an increased demand for mobile and portable imaging equipment.
Increased demand for COVID-19 imaging: The pandemic has led to an increased demand for imaging technologies, such as CT scans and X-rays, for the diagnosis and monitoring of COVID-19 patients. This has resulted in a shift in focus towards COVID-19 imaging, leading to a decline in the demand for other imaging modalities.
Investments in research and development: The COVID-19 pandemic has highlighted the importance of imaging technologies in the diagnosis and treatment of diseases. As a result, there has been an increased focus on research and development in the bio-imaging market to develop new imaging technologies and applications for COVID-19 and other diseases. Overall, the COVID-19 pandemic has had a mixed impact on the bio-imaging market. While the pandemic has led to a decline in the demand for bio-imaging technologies, it has also led to an increased focus on the importance of imaging technologies in healthcare and an increased investment in research and development.
Regional Trend
The bio-imaging market is a global market, with significant demand across various regions. Here is a regional analysis of the bio-imaging market: North America: North America is one of the largest markets for bio-imaging, driven by factors such as the presence of a large number of key players, a high prevalence of chronic diseases, and advanced healthcare infrastructure. The US is the largest market for bio-imaging in North America, accounting for the majority of the market share.
Europe: Europe is also a significant market for bio-imaging, with factors such as increasing healthcare expenditure, a high prevalence of chronic diseases, and a well-established healthcare infrastructure driving the demand for bio-imaging technologies. Germany, France, and the UK are the largest markets for bio-imaging in Europe.
Asia Pacific: Asia Pacific is expected to be the fastest-growing market for bio-imaging, driven by factors such as the growing prevalence of chronic diseases, increasing healthcare expenditure, and the presence of a large patient population. China and India are the largest markets for bio-imaging in Asia Pacific.
Latin America: Latin America is a growing market for bio-imaging, with factors such as increasing healthcare expenditure, a growing prevalence of chronic diseases, and improving healthcare infrastructure driving the demand for bio-imaging technologies. Brazil and Mexico are the largest markets for bio-imaging in Latin America.
Middle East and Africa: The Middle East and Africa region is a growing market for bio-imaging, driven by factors such as increasing healthcare expenditure, a growing prevalence of chronic diseases, and improving healthcare infrastructure. South Africa and Saudi Arabia are the largest markets for bio-imaging in the Middle East and Africa region. Overall, the bio-imaging market is expected to witness significant growth across all regions, driven by the increasing prevalence of chronic diseases, growing healthcare expenditure, and the development of advanced imaging technologies.
Competitive Landscape
The bio-imaging market is highly competitive, with the presence of several key players. Here are some of the major players in the bio-imaging market:
GE Healthcare: GE Healthcare is a leading provider of bio-imaging equipment and services, with a portfolio that includes X-ray, CT, MRI, and ultrasound imaging systems. The company has a strong global presence and a wide range of imaging products.
Siemens Healthineers: Siemens Healthineers is a leading provider of medical imaging systems, including CT, MRI, PET/CT, and ultrasound systems. The company also offers a range of services, including imaging software and consulting.
Canon Medical Systems: Canon Medical Systems is a leading provider of medical imaging systems, including CT, MRI, and ultrasound systems. The company also offers a range of software and services to support its imaging products.
Philips Healthcare: Philips Healthcare is a global leader in healthcare technology, with a strong presence in the bio-imaging market. The company offers a range of imaging systems, including CT, MRI, and ultrasound systems, as well as advanced imaging software and services.
Fujifilm Holdings: Fujifilm Holdings is a leading provider of medical imaging systems, including X-ray, CT, and ultrasound systems. The company also offers a range of imaging software and services to support its imaging products.
Hitachi Medical Systems: Hitachi Medical Systems is a leading provider of medical imaging systems, including MRI, CT, and ultrasound systems. The company also offers a range of software and services to support its imaging products.
Hologic: Hologic is a leading provider of medical imaging systems, with a focus on women's health. The company offers a range of imaging systems, including mammography and bone densitometry systems, as well as advanced imaging software and services.
Other key players in the bio-imaging market include Carestream Health, Shimadzu Corporation, and Koninklijke Philips N.V. Overall, the bio-imaging market is highly competitive, with key players focused on developing advanced imaging technologies, expanding their global presence, and offering comprehensive imaging solutions and services to healthcare providers.
Market Segmentation
The bio-imaging market can be segmented based on various factors, including technology, application, end-user, and geography.
Here are some of the major market segments in the bio-imaging market:
By Technology:
X-ray imaging
Magnetic resonance imaging (MRI)
Computed tomography (CT)
Ultrasound imaging
Nuclear imaging
Optical imaging
By Application:
Cardiology
Oncology
Neurology
Orthopedics
Gastroenterology
Gynecology
Other applications (pulmonology, urology, and dermatology)
By End-user:
Hospitals
Diagnostic imaging centers
Research institutes
Others (ambulatory surgical centers, clinics, and home healthcare settings)
By Geography:
North America
Europe
Asia Pacific
Latin America
Middle East and Africa
Overall, the bio-imaging market is expected to witness significant growth across all technology segments and applications, driven by the increasing prevalence of chronic diseases and the development of advanced imaging technologies. The hospital segment is expected to be the largest end-user segment in the bio-imaging market, owing to the high demand for imaging services in hospital settings. North America and Europe are expected to be the largest markets for bio-imaging, owing to the high healthcare expenditure and the presence of key players in these regions. However, the Asia Pacific region is expected to witness the highest growth in the bio-imaging market, owing to the increasing healthcare expenditure and the growing patient population in this region
Base Year: 2023
Historic Year: 2016-2022
Forecast: 2024-2035